PCM
HQCL

Prelude Capital Management’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Prelude Capital Management’s Portfolio HQCL Stock Details HQCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$2K – 1927
2016
Q4 		$2K Sell
200
-100
-33% -$982 ﹤0.01% 1493
2016
Q3 		$3K Buy
300
+100
+50% +$1.28K ﹤0.01% 1522
2016
Q2 		$3K Buy
+200
New +$2.59K ﹤0.01% 1496

Other funds holding HQCL

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

Prelude Capital Management's HQCL Position: Q1 2017 in Review

Prelude Capital Management sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q1 2017, closing a stake of 200 shares — an estimated $2K sold.

Prelude Capital Management first reported a position in HQCL in Q2 2016 and held it in 3 quarters. The position peaked at $3K in Q3 2016. 13 funds tracked by Wall St. Rank hold HQCL as of Q1 2017.

  • Prelude Capital Management reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q1 2017 after selling out during the quarter.
  • Prelude Capital Management sold 200 Hanwha Q CELLS Co., Ltd. shares in Q1 2017, an estimated $2K.
  • Prelude Capital Management first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2016 and held it in 3 quarters.
  • Prelude Capital Management's Hanwha Q CELLS Co., Ltd. position peaked at $3K in Q3 2016.
  • 13 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q1 2017.

Based on Prelude Capital Management's 13F filing for Q1 2017, filed 15 May 2017.